Foundation Staff

Eric R. Braverman

Eric R. Braverman, M.D.

Founder and President

Eric R. Braverman, M.D. is the founder and president of PATH Foundation NY, a non-profit research organization devoted to establishing how the brain functions and using that information to develop practical diagnostic and treatment methods that improve wellbeing and increase longevity. He currently holds an appointment as Courtesy Assistant Professor at the University of Florida College of Medicine and the McKnight Brain Institute. Dr. Braverman graduated from NYU School of Medicine with honors and completed his residency at Greenwich Hospital, a Yale University School of Medicine affiliate. He assisted with folic acid studies at Harvard Medical School and contributed to brain and nutrition studies at the Princeton Brain Bio Center. He is the author of several best-selling books on brain/body health and nutrition. He is also the founder and medical director of PATH Medical in New York, where his life's work is dedicated to serving patients by balancing the brain's chemistry and conquering obesity, addiction, and memory loss. He utilizes the integration of all medical specialties for the singular purpose of life extension through total health.

Kenneth Blum, Ph.D.

Kenneth Blum, Ph.D.

Scientific Director

Kenneth Blum, PhD is currently Chairman of the Board and Chief Scientific Officer of LifeGen, Inc. San Diego, California and managing partner of Reward Deficiency Solutions, LLC, in San Diego, California. He serves as Senior Scientific Advisor for G & G Holistic Addictions Treatment Center, North Miami Beach, Florida, USA. He is currently Full Professor of the Department of Psychiatry and McKnight Brain Institute University of Florida College of Medicine, Gainesville Florida.

Dr. Blum's work at PATH Foundation extends into many different areas from hands-on research to mentoring our young and bright PATH scholars. Dr. Blum is currently working on several studies which include the effects of Hormone Replacement Therapy (HRT) on menopausal women and the benefits of chelation therapy in urban environments. Both his time and efforts have helped the Foundation to grow scientifically and move forward with prospective studies.

He has received numerous awards including NIDA Career Teacher Award; American Chemical Society Speakers Award; Gordon Conference Research Award; Presidential Excellence award (National Council of Alcoholism and Drug Abuse). Dr Blum has authored and edited eleven books and has published over 400 peer reviewed papers. He coined "Brain Reward Cascade and Reward Deficiency Syndrome (RDS)" and is credited as the lead author in the first association of the Dopamine D2 receptor gene with severe alcoholism (JAMA, 1990). He is considered by many as the father of "Psychiatric Genetics." He is credited with co-discovering the first gene [DOPAMINE D2 RECEPTOR GENE] to associate with not only alcoholism but reward dependence in general. He holds over 20 patents. He is also the father of Neuroadaptagen Amino-Acid Therapy (NAAT) for the recovery field.

Dr. Blum's research has been covered by every major newspaper in the world and he has made numerous television appearances. He has been featured in Time, Newsweek, Business, O magazine, Discover Magazine, American Scientist, Economics, among many others. His work has received both Silver and Bronze medals from The Natural Products Association in 2006 and 2007. Dr Blum has published in almost every major scientific journal worldwide-: Science; Lancet; Nature; PNAS, JAMA among others. He is actively investigating the role of natural dopamine agonists as an anti craving DNA directed therapeutic target for prevention of relapse.